CDMO's logo.
Ticker Symbol: CDMO

Avid Bioservices Inc

$33.10 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: United States Currency: USD Asset Type: Common Stock CIK:0000704562

Company Profile

Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 28 years of experience producing monoclonal antibodies and recombinant proteins, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 2642 Michelle Dr Ste 200
Website: avidbio.com
CEO: Richard Hancock
Tags:
  • Health Technology
  • Medical Specialties
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $6.70
Change: -$0.27 ( -3.87%)
Days Range: $6.65 - $6.98
Beta: 1.57
52wk. High: $21.05
52wk. Low: $6.96
Ytd. Change -53.26%
50 Day Moving Average: $9.74
200 Day Moving Average: $13.90
Shares Outstanding: 63112934

Valuation

Market Cap: 42.3B
PE Ratio: -137.58
EPS (TTM): -0.0487

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A